X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://svt.com/en/salvat-laboratories-presented-phase-iii-clinical-trials-results-of-clobetasol-nanoemulsion-for-treating-inflammation-and-pain-after-ocular-surgery-at-the-2023-arvo-annual-meeting/
https://www.contractpharma.com/contents/view_breaking-news/2022-10-31/salvat-laboratories-submits-nda-to-fda/9769
https://www.fiercepharma.com/pharma/salvat-heads-regulators-phase-3-data-ocular-steroid
https://www.fiercepharma.com/pharma/salvat-heads-regulators-phase-3-data-ocular-steroid
https://www.prnewswire.com/news-releases/global-glaucoma-pipeline-guide-h1-2020--provides-data-for-therapeutics-under-development-by-stage-of-development-drug-target-mechanism-of-action-route-of-administration-and-molecule-type-301045394.html
https://www.oaoa.com/news/business/article_24e530cc-5160-59d0-9e29-7a6e0be86657.html
http://thewalkingdeadfrance.org/produits-bfs-blow-fill-seal-analyse-actuelle-du-marche-jusquen-2029/
http://svt.com/en/the-spanish-ministry-of-industry-maintains-the-rating-of-very-good-to-laboratorios-salvat-sa-in-the-profarma-2019-program/
http://svt.com/en/laboratorios-salvat-leads-the-development-of-the-first-treatment-for-otomycosis/
https://www.immedicohospitalario.es/noticia/18221/laboratorios-salvat-desarrolla-el-primer-farmaco-para-el-tratamiento
Market Place
Share 
